Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Tamoxifen effectively treats gynecomastia without causing impotence.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Created microspheres show potential for safe and effective use in prostate artery embolization.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.